Leslie Sloan
2020
In 2020, Leslie Sloan earned a total compensation of $1.2M as Chief Operating Officer at Aeglea BioTherapeutics, a 8% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $148,000 |
|---|---|
| Salary | $370,000 |
| Stock Awards | $707,970 |
| Other | $20,349 |
| Total | $1,246,319 |
Sloan received $708K in stock awards, accounting for 57% of the total pay in 2020.
Sloan also received $148K in non-equity incentive plan, $370K in salary and $20.3K in other compensation.
Rankings
In 2020, Leslie Sloan's compensation ranked 7,665th out of 13,090 executives tracked by ExecPay. In other words, Sloan earned more than 41.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,665 out of 13,090 | 41st |
Division Manufacturing | 3,235 out of 5,620 | 42nd |
Major group Chemicals And Allied Products | 1,307 out of 2,253 | 42nd |
Industry group Drugs | 1,131 out of 1,953 | 42nd |
Industry Pharmaceutical Preparations | 844 out of 1,458 | 42nd |
Source: SEC filing on April 21, 2022.
Sloan's colleagues
We found one more compensation record of an executive who worked with Leslie Sloan at Aeglea BioTherapeutics in 2020.
2020
Anthony Quinn
Aeglea BioTherapeutics